Analyzing Marpai (NASDAQ:MRAI) and NewGenIvf Group (NASDAQ:NIVF)

Marpai (NASDAQ:MRAI) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership.

Insider and Institutional Ownership

49.8% of Marpai shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 61.3% of Marpai shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations for Marpai and NewGenIvf Group, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marpai	0	0	1	0	3.00
NewGenIvf Group	0	0	0	0	N/A

Marpai presently has a consensus target price of $6.00, suggesting a potential upside of 890.82%. Given Marpai’s higher probable upside, equities analysts plainly believe Marpai is more favorable than NewGenIvf Group.

Profitability

This table compares Marpai and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Marpai	-92.76%	N/A	-99.32%
NewGenIvf Group	N/A	N/A	N/A

Risk and Volatility

Marpai has a beta of 4.85, indicating that its stock price is 385% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.29, indicating that its stock price is 71% less volatile than the S&P 500.

Earnings & Valuation

This table compares Marpai and NewGenIvf Group”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marpai	$34.87 million	0.19	-$28.75 million	($3.19)	-0.19
NewGenIvf Group	$5.14 million	0.50	$130,000.00	N/A	N/A

NewGenIvf Group has lower revenue, but higher earnings than Marpai.

About Marpai

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

About NewGenIvf Group

A SPAC I Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. A SPAC I Acquisition Corp. is based in Singapore.